TP53 and sarcoma: In sarcomas, malignant tumours resembling mesenchymal tissue, amplification of MDM2 (murine double minute 2) is relatively common (20%) in tumours having TP53Wt, resulting in disabled p53 function because overexpressed MDM2 protein binds to and inactivates p53 [2,3].